Sean X Hu
Global Data,USA
Biography
Hu is currently Senior Vice President and Head of Consulting in the US for the Pharmaceutical and Diagnostics industries at GlobalData Inc., a publicly listed global healthcare business intelligence and management consulting firm with a headquarter in London, UK. Earlier, aside from being the founding President of BioStrat Advisory LLC, for years he was the Managing Partner and Head of Bionest USA, both life science industry strategy consulting firms in the US. An early participant of the Human Genome Project and later involved in the International HapMap Project, Dr. Hu is now a recognized thought leader in the field of personalized / precision medicine (PM) business strategy, advising global pharmaceutical and diagnostics companies on how best to develop and commercialize personalized medicine drug and / or molecular diagnostics, and build internal business processes & capabilities for PM products. He currently serves on the Editorial Board of the peer-reviewed journal Personalized Medicine, in addition to several PM related industry consortia/committees. For example, he was the only representative from the management consulting industry invited to the US FDA Personalized Medicine Initiative, and co-organized / co-chaired a two-day conference / workshop on Personalized Medicine Strategic Decision Making onsite at the US FDA campus. He was also a Member of the BioNJ PM & Molecular Diagnostics Committee. He has been a frequently invited speaker on PM at conferences and to the leadership teams of many pharmaceutical companies, along with some notable business publications on this subject, including two (co-) first-authored papers in Nature Reviews, and such other journals as Supplement to Science and Personalized Medicine. As part of his extracurricular activities, he holds an Adjunct Professor position at the Chinese National Human Genome Center at Shanghai, Chinese Academy of Sciences, and Senior Advisor & Visiting Professor positions at the Beijing Genomics Institute. For years, he served as the Greater New York / New Jersey Regional Leader for BayHelix, a semi-exclusive club of global life science industry business executives of Chinese heritage. Dr. Hu’s earlier work experience includes serving at such other consulting firms as IMS Consulting and AT Kearney, BMS – a major pharma, Illumina – a prominent genetic analysis tool/diagnostics company, and CuraGen – a first-generation genomics biopharma. Dr. Hu obtained his PhD in Genomics from New York University, and MBA from the Wharton School of Business, University of Pennsylvania, with double majors in Strategic and Entrepreneurial Management.
Abstract
Abstract : Title: Precision/Personalized Medicine: Encouraging Trend, but Major Challenges Ahead?